The All-Safe Signal: VIP, α-MSH, and the Molecules That Tell the Body to Stand Down

In the final phase of recovery, treatment shifts from clearing threats to sending a single message the body has been unable to receive: you are safe. That message is carried by specific molecules — and getting them to land is the last, most delicate step.

The stand-down messengers

A small set of neuropeptides act as the body’s all-clear. Chief among them is VIP (vasoactive intestinal polypeptide), a master pro-resolution signal that is often 30–60% below normal in biotoxin illness. α-MSH is another; oxytocin adds a social dimension.

It is, in the most literal sense, a chemical “you are safe with others” signal. — Andrew Heyman, MD

Why VIP goes last, not first

It is tempting to reach for the all-safe signal early. But sent to a body still under threat or still running on empty, it disappoints — because the prerequisites are not met. VIP is deployed only on a secured foundation.

A poor VIP response is, far more often than not, a missed environmental source or incomplete prerequisite. — Andrew Heyman, MD

A poor response points upstream

If the safety signal does not work, the answer is rarely “more signal.” It is to look back a step — a lingering exposure, an unfinished phase — because the peptide can only do its job once the body is ready to hear it.

The takeaway

The end of recovery is not a bigger hammer; it is a message finally being received. Restoring the body’s own safety signaling — through nervous-system work and, once the gate is met, the peptides themselves — is how the danger program is told, at last, to close.